AGIO vs AWK · rev $36.5M vs P/E 22, rev $4.65B
Agios Pharm (AGIO) versus American Water Works (AWK) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Latest reported AGIO revenue for 2024-12-31 was $36.5M. Net income was $673.7M. Revenue was up 36.1% from 2023-12-31 to 2024-12-31. AGIO currently screens at market cap $1.68B.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
AGIO currently screens at market cap $1.68B. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Not investment advice. Open the AGIO and AWK stock pages for the full models.
Not investment advice.